HERMES Medical Solutions (HERMES) by Sofia Bertling COO and Vanderbilt University (Vanderbilt) by Professor Michael Stabin announced today the signature of an exclusive license and commercialization agreement for the new dosimetry application OLINDA / EXM® to be distributed by HERMES.
The OLINDA / EXM® application is widely used in the radiopharmaceutical industry and research community for internal dose calculations of radiopharmaceuticals. The new version has been enhanced and includes new human models and nuclides. HERMES will continue the development, regulatory, manufacturing and commercial leadership of OLINDA / EXM® .
“OLINDA / EXM® is in line with HERMES focus on individualized treatment planning and will facilitate patient dose decisions”, says Sofia Bertling, COO at HERMES and Professor Michael Stabin.
ABOUT HERMES MEDICAL SOLUTIONS HERMES Medical Solutions, located in Stockholm, Sweden, is a private limited company founded 1976. Headquarters are located in Stockholm, Sweden with offices in North America, Europe and Asia. HERMES partners with the best institutions globally to continually deliver state-of-the-art software to meet and exceed medical imaging needs.
ABOUT VANDERBILT UNIVERSITY Vanderbilt University, located in Nashville, Tennessee, U.S., is a private research university and medical center founded 1873. The University is top-ranked in several areas including its Department of Radiology and Radiological Sciences which is a leader in Nuclear Medicine Dosimetry. OLINDA / EXM® is a registered trademark of Vanderbilt University, Nashville, Tennessee, U.S.A.